Short answer
Ardent Health, Inc. (ARDT) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Ardent Health reported third-quarter fiscal 2026 results for the period ended September 30, 2026.
Ardent Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Ardent Health reported third-quarter fiscal 2026 results for the period ended September 30, 2026
- Press release issued November 4, 2026, with detailed financial results in Exhibit 99.1
- Results announcement gives investors the latest operating update for Ardent Health’s quarterly performance
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $1.625B, up 3.1% YoY, while adjusted admissions grew 2.9%, signaling improving utilization
- Net income attributable to Ardent $45M, or $0.31 diluted EPS, versus a $23M loss, or $(0.17), last year
- Adjusted EBITDA $138M, supported by 4% lower salaries, wages and benefits expense and IMPACT savings targeting at least $70M
- 2026 adjusted EBITDA guidance raised to $500M-$535M from $485M-$535M, with revenue guidance maintained at $6.4B-$6.7B
- Liquidity $1B, cash $766M, lease-adjusted net leverage 2.5x, plus $25M added to repurchase authorization
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Ardent Health, Inc. 8-K filings
Get the next ARDT 8-K as it lands
Follow ARDT for push alerts, or ask the research agent what this filing means.